Volume 6, Issue 10. Christopher Oermann, MD covers the important topic of the Pseudomonas Eradication in the format of case-study scenarios for the clinical practice. Take our post-test to claim CME credits: Physician post-test Nurse post-test To read ...

Volume 6, Issue 8. Dr. Deepak Agrawal, MD covers the important topic of Nutritional Issues in Cystic Fibrosis in the format of case-study scenarios for the clinical practice. Take our post-test to claim CME credits: Physician post-test Nurse post-test ...

Volume 6, Issue 6. Daniel Heintz, MD and Karen McCoy, MD cover the important topic of Trends in Inhaled Antibiotic Therapy in the format of case-study scenarios for the clinical practice.

Volume 6, Issue 4. Our guest author is John J. LiPuma from the University of Michigan in Ann Arbor, Michigan.

Volume 6, Issue 2. In this issue we are joined by one of our Program Directors, Dr. Noah Lechtzin from the Johns Hopkins University. Dr. Lechtzin will address the current state of CFTR modification and how it can be applied in practice.

Special Edition 2015, Part 4. Join us as Dr. Patrick Flume of the Medical University of South Carolina interviews Dr. Stuart Elborn of Queen’s University in Belfast, Ireland. Dr. Elborn discusses the implications of the CAT study and how it effects his...

Special Edition 2015, Part 3. Join us as Dr. Patrick Flume of the Medical University of South Carolina interviews Dr. JP Clancy of Cincinnati Children’s Hospital. Dr. Clancy discusses the implications of the CAT study and how it effect his practice.

Special Edition 2015, Part 2. Join us as Dr. Patrick Flume of the Medical University of South Carolina interviews Dr. Scott Bell of the QIMR Berghofer Medical Research Institute. Dr. Bell discusses the implications of the CAT study and how it will effe...

Special Edition 2015, Part 1. Join us as Dr. Peter Mogayzel of the Johns Hopkins University discusses the design and findings for the CAT study with Dr. Patrick Flume of the Medical University of South Carolina.

Volume 5, Issue 14. In this issue we are joined by Dr. Shawn Aaron of University of Ottawa in Ontario, Canada. Dr. Aaron will discuss infection in patients with optimal therapy of chronic Pseudomonas aeruginosa cystic fibrosis,